Kircali, E. Et Al. 2022. Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome. BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1 , 206-207.

Kircali, E., CENGİZ SEVAL, G., Bozdag, S. C., Yuksel, M. K., Topcuoglu, P., Arslan, O., ... Ozcan, M.(2022). Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome. BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, 206-207.

Kircali, E. Et Al. "Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome," BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, 206-207, 2022

Kircali, E. Et Al. "Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome." BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.206-207, 2022

Kircali, E. Et Al. (2022) . "Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome." BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.206-207.

@article{article, author={E. Kircali Et Al. }, title={Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome}, journal={BONE MARROW TRANSPLANTATION}, year=2022, pages={206-207} }